Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Spectrum: Phase II Study of Tislelizumab Plus Pemetrexed in Patients with Relapsed or Refractory (R/R) Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): The Korean Cancer Study Group LY22-07

Tae Min Kim, Jung Sun Kim, Gyeong-Won Lee, Myung-Won Lee, Jeonghwan Youk, Hyun Jung Lee, Sung-Nam Lim, Soyeon Kim, Yoon Kyung Jeon, Chul-Kee Park, Dae Seog Heo

Blood (2024) 144 (Supplement 1): 3102.

https://doi.org/10.1182/blood-2024-202877

Published: 2024

Journal Articles

Lysosome Dysfunction Contributes to Myeloproliferative Neoplasm Development Via Oncostatin-M Dependent Inflammation

Hyundong Yoon, Seulki Song, Dohoon Lee, Bonil Koo, Jihyun Park, Tae Kon Kim, Sun Kim, Youngil Koh, Sung-Soo Yoon

Blood (2022) 140 (Supplement 1): 12183–12184.

https://doi.org/10.1182/blood-2022-167989

Published: 2022

Journal Articles

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

Blood (2022) 140 (Supplement 1): 8985–8986.

https://doi.org/10.1182/blood-2022-170279

Published: 2022

Journal Articles

Exploration of the Appropriate NT-Probnp Level for AL Amyloidosis Staging

Hana Kim, Darae Kim, Jinoh Choi, Eunseok Jeon, Jung Eun Lee, Ju Hong Min, Joon Young Choi, Jung-Sun Kim, Seokjin Kim, Kihyun Kim

Blood (2021) 138 (Supplement 1): 3777.

https://doi.org/10.1182/blood-2021-151675

Published: 2021

Journal Articles

A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy

Blood (2021) 138 (Supplement 1): 184.

https://doi.org/10.1182/blood-2021-146398

Published: 2021

Journal Articles

Real World (RW) Outcomes and Prognostication of Older Patients with Primary Central Nervous System Lymphoma (PCNSL) in the Contemporary Era

Blood (2020) 136 (Supplement 1): 24–26.

https://doi.org/10.1182/blood-2020-136551

Published: 2020

Journal Articles

EBV-Positive Primary CNS Lymphomas in Older Patients: Incidence, Characteristics, Tumor Pathology, and Outcomes across a Large Multicenter Cohort

Prashasti Agrawal, Kevin A. David, MD, Zhengming Chen, PhD MPH, MS, Suchitra Sundaram, MD, Seo-Hyun Kim, MD, Ryan Vaca, MD, Yong Lin, PhD, Samuel Singer, MD, Mary-Kate Malecek, MD, Jordan Carter, MD, Adam Zayac, MD, Myung Sun Kim, MD, Nishitha Reddy, MD, Alma Habib, MD, Christopher Strouse, MD, Jerome Graber, MD, Veronika Bachanova, MD PhD, Mazie Tsang, MD, Ajay Major, MDMBA, David A. Bond, MD, Angel Mier-Hicks, MD, Pallawi Torka, MD, Priya Rajakumar, MD, Parameswaran Venugopal, MD, Michael Glantz, MD PhD, Samuel Goldlust, MD, Rahul Matnani, MD, Pallavi Kumar, MD, Thomas A Ollila, MD, Johnny Cai, DO, Stephen E. Spurgeon, MD, Alex G Sieg, MD MS, Joseph Cleveland, MD, Narendranath Epperla, MDMS, Reem Karmali, MDMSc, Seema Naik, MD, Sonali M. Smith, MD, James L. Rubenstein, MD PhD, Brad S. Kahl, MD, Amy Chadburn, MD, Andrew M. Evens, DO,MMSc, Peter Martin, FRCPC, MD MS

Blood (2020) 136 (Supplement 1): 4–6.

https://doi.org/10.1182/blood-2020-138885

Published: 2020

Journal Articles

Risk Stratification Integrating Deauville Score on Interim PET-CT Scan and Baseline International Prognostic Index in Diffuse Large B-Cell Lymphoma Patients

Ho-Young Yhim, MD PhD, Sung Kyun Yim, So Yeon Jeon, MD, Yeon-Hee Han, MD, Myung-Hee Sohn, Na-Ri Lee, Eun-Kee Song, MD, Chang-Yeol Yim, Hee Sun Kim, Jae-Yong Kwak, MD PhD

Blood (2018) 132 (Supplement 1): 1698.

https://doi.org/10.1182/blood-2018-99-114365

Published: 2018

Journal Articles

Bortezomib-Based First Line Treatment for AL Amyloidosis Patients Who Are Not Candidate for Stem Cell Transplantaion

Joon Young Hur, MD, Kang Kook Lee, MD, Sang Eun Yoon, MD, Sehhoon Park, MD, Jangho Cho, MD, Youjin Kim, MD, Eunseok Jeon, MD PhD, Jinoh Choi, MD PhD, Gayeon Lee, MD PhD, Byungjun Kim, MD PhD, Ju Hong Min, MD PhD, Jung Sun Kim, MD PhD, Jung Eun Lee, MD PhD, Joon Young Choi, MD PhD, Seok Jin Kim, MD PhD, Jun Ho Jang, MD PhD, Won-Seog Kim, MD PhD, Chul Won Jung, MD PhD, Kihyun Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3256.

https://doi.org/10.1182/blood-2018-99-114099

Published: 2018

Journal Articles

Efficacy of Bortezomib-Based Regimens for Patients with Newly Diagnosed AL Amyloidosis Not Receiving ASCT Compared with Alkylators and Dexamethasone-Based Regimens

Blood (2017) 130 (Supplement 1): 3114.

https://doi.org/10.1182/blood.V130.Suppl_1.3114.3114

Published: 2017

Journal Articles

Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

Ho-Young Yhim, MD PhD, Na Ri Lee, MD PhD, Eun-Kee Song, MD PhD, Chang-Yeol Yim, MD PhD, So Yeon Jeon, MD, Bohee Lee, MD, Jeong-A Kim, MD PhD, Hee Sun Kim, Eun Hae Cho, Jae-Yong Kwak, MD PhD

Blood (2014) 124 (21): 4553.

https://doi.org/10.1182/blood.V124.21.4553.4553

Published: 2014

Journal Articles

Interim Positron Emission Tomography Scan Predicts Early Outcomes Of Patients With Peripheral T-Cell Lymphoma

Ho-Young Yhim, MD, Na-Ri Lee, Eun-Kee Song, So Yeon Jeon, Chang-Yeol Yim, Yeon-Hee Han, Myung-Hee Sohn, Bohee Lee, MD, Jeong-A Kim, MD, PhD, Young Ha Park, Woo Hee Choi, Hee Sun Kim, Jae-Yong Kwak

Blood (2013) 122 (21): 4364.

https://doi.org/10.1182/blood.V122.21.4364.4364

Published: 2013

Journal Articles

Combined Analysis Using Visual and SUV-Based Quantitative Assessments Improves Predictive Value of Interim Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Ho-Young Yhim, MD, Na-Ri Lee, Eun-Kee Song, So Yeon Jeon, Chang-Yeol Yim, Yeon-Hee Han, Myung-Hee Sohn, Bohee Lee, Jeong-A Kim, MD.PhD., Young Ha Park, Woo Hee Choi, Hee Sun Kim, Jae-Yong Kwak

Blood (2012) 120 (21): 3690.

https://doi.org/10.1182/blood.V120.21.3690.3690

Published: 2012

Journal Articles

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells

Daniel Smrž, Mi-Sun Kim, Shuling Zhang, Beverly A. Mock, Šárka Smržová, Wendy DuBois, Olga Simakova, Irina Maric, Todd M. Wilson, Dean D. Metcalfe, Alasdair M. Gilfillan

Blood (2011) 118 (26): 6803–6813.

https://doi.org/10.1182/blood-2011-06-359984

Published: 2011

Includes: Supplemental data

Journal Articles

Successful Mobilization with the Combination of Plerixafor and G-CSF in Korean Pediatric Patients Who Failed in Previous Chemomobilization with G-CSF Alone

Hyoung Jin Kang, Kyung Taek Hong, Nam Hee Kim, Min Sun Kim, Ji Won Lee, Hyery Kim, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn

Blood (2011) 118 (21): 4397.

https://doi.org/10.1182/blood.V118.21.4397.4397

Published: 2011

Journal Articles

Fludarabine Plus I-131 Tositumomab as Initial Treatment for Follicular Lymphoma: Half of Patients In Remission at Over 10 Years Median Followup.

Peter Martin, FRCPC, MD, MS, Morton Coleman, MD, Richard R. Furman, MD, Shankar Vallabhajosula, Dong Sun Kim, Andrew Edelstein, Julia Morrison, Rebecca Elstrom, MD, Jia Ruan, MD, PhD, Stanley J. Goldsmith, John P. Leonard, MD

Blood (2010) 116 (21): 1785.

https://doi.org/10.1182/blood.V116.21.1785.1785

Published: 2010

Journal Articles

FactorVIII Gene Modifications Observed in Acquired Hemophilia.

Sung Ho Hwang, Hugh C Kim, M.D., Jeonga Lim, Hyun Woo Lee, M., D., Seong Hyun Jeong, Joon Seong Park, MD, Hye Sun Kim, PhD

Blood (2009) 114 (22): 4450.

https://doi.org/10.1182/blood.V114.22.4450.4450

Published: 2009

Journal Articles

Aberrant DNA Methylation in Childhood Acute Lymphoblastic Leukemia as a Potential Biomarker Reflecting Disease Status.

Seung Yeon Kwon, Sung Chul Won, Hyo Sun Kim, Hei-Cheul Jeung, Sun Young Rha, Kyu Hyun Park, Jaewoo Song, MD, Chuhl Joo Lyu, MD, PhD

Blood (2009) 114 (22): 2637.

https://doi.org/10.1182/blood.V114.22.2637.2637

Published: 2009

Journal Articles

Identification of Genes Associated with Inhibitor Development in Hemophilia a by Microarray Analysis.

Sung Ho Hwang, PhD, Hugh C Kim, M.D., Hyun Woo Lee, M.D., Ki young Yoo, M.D., Hyon J Kim, M.D., Hye Sun Kim, PhD

Blood (2008) 112 (11): 2271.

https://doi.org/10.1182/blood.V112.11.2271.2271

Published: 2008

Journal Articles

Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.

Seok Jin Kim, MD, PhD, Hwa Jung Sung, MD, PhD, Chul Won Choi, MD, PhD, In Sun Kim, MD, PhD, Byung Soo Kim, MD, PhD, Soo-Young Yoon, MD, PhD, Jong-Ho Won, MD, PhD, Jun Suk Kim, MD, PhD

Blood (2007) 110 (11): 1575.

https://doi.org/10.1182/blood.V110.11.1575.1575

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Spectrum: Phase II Study of Tislelizumab Plus Pemetrexed in Patients with Relapsed or Refractory (R/R) Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): The Korean Cancer Study Group LY22-07

Lysosome Dysfunction Contributes to Myeloproliferative Neoplasm Development Via Oncostatin-M Dependent Inflammation

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

Exploration of the Appropriate NT-Probnp Level for AL Amyloidosis Staging

A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy

Real World (RW) Outcomes and Prognostication of Older Patients with Primary Central Nervous System Lymphoma (PCNSL) in the Contemporary Era

EBV-Positive Primary CNS Lymphomas in Older Patients: Incidence, Characteristics, Tumor Pathology, and Outcomes across a Large Multicenter Cohort

Risk Stratification Integrating Deauville Score on Interim PET-CT Scan and Baseline International Prognostic Index in Diffuse Large B-Cell Lymphoma Patients

Bortezomib-Based First Line Treatment for AL Amyloidosis Patients Who Are Not Candidate for Stem Cell Transplantaion

Efficacy of Bortezomib-Based Regimens for Patients with Newly Diagnosed AL Amyloidosis Not Receiving ASCT Compared with Alkylators and Dexamethasone-Based Regimens

Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

Interim Positron Emission Tomography Scan Predicts Early Outcomes Of Patients With Peripheral T-Cell Lymphoma

Combined Analysis Using Visual and SUV-Based Quantitative Assessments Improves Predictive Value of Interim Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells

Successful Mobilization with the Combination of Plerixafor and G-CSF in Korean Pediatric Patients Who Failed in Previous Chemomobilization with G-CSF Alone

Fludarabine Plus I-131 Tositumomab as Initial Treatment for Follicular Lymphoma: Half of Patients In Remission at Over 10 Years Median Followup.

FactorVIII Gene Modifications Observed in Acquired Hemophilia.

Aberrant DNA Methylation in Childhood Acute Lymphoblastic Leukemia as a Potential Biomarker Reflecting Disease Status.

Identification of Genes Associated with Inhibitor Development in Hemophilia a by Microarray Analysis.

Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only